HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: HIV Prevention for Injecting Drug Users in Kazakhstan [Phase 2]
A Phase 2 clinical trial on HIV prevention among injecting drug users in Kazakhstan has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection [Phase 1]
This ClinicalTrials.gov entry reports the completion of a Phase 1 trial of an HIV-1 peptide immunization with adjuvant in adults with chroni…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users [NA]
This ClinicalTrials.gov entry reports the completion of a community-friendly risk reduction intervention trial for injection drug users; the…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders [Phase 2]
Phase 2 trial of multimedia HIV/STI prevention for drug-involved female offenders has completed.
-
FDA label_change · 2014-02-26FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Reyataz (atazanavir) to update the labeling following submission by E.R. Squibb & Sons, L.L.C.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Dendritic Cell Vaccine in HIV-1 Infection [Phase 1, Phase 2]
A dendritic cell vaccine trial in HIV infection has completed Phase 1/2 testing.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART [Phase 1, Phase 2]
Phase 1/2 trial update assessing the safety and HIV-1 expression effects of the HDAC inhibitor panobinostat in patients on suppressive antir…
-
FDA approval · 2014-02-20FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for EMTRIVA (emtricitabine) filed by Gilead Sciences, Inc., updating the drug's labeling and/or …
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir [Phase 3]
Phase 3 trial evaluating dolutegravir in HIV-1 infected subjects with resistance to raltegravir and/or elvitegravir; results have been poste…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Violence and HIV Risk Among Women [NA]
This entry notes the University of Rochester–sponsored trial studying violence and HIV risk reduction among women has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment [Phase 4]
Phase 4 trial evaluating whether presumptive tuberculosis treatment can prevent early mortality in people with HIV infection; the study was …
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
A clinical trial update on HIV-1 participants treated with antiretroviral therapy that included raltegravir (MK-0518-138); the trial is comp…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens [Phase 4]
Phase 4 study comparing lopinavir/ritonavir monotherapy with darunavir/ritonavir monotherapy as simplification switches from PI/NNRTI-triple…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating growth hormone and/or rosiglitazone for HIV-associated lipodystrophy syndrome with insulin resista…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Early Versus Delayed Pneumococcal Vaccination in HIV [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated early versus delayed pneumococcal vaccination in individuals with HIV and has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: CSP #512 - Options in Management With Anti-Retrovirals [NA]
This document reports an update on the CSP #512 trial evaluating management options with antiretrovirals; the study is completed and results…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus [Phase 1]
Phase 1 trial evaluating AMD11070 in HIV-infected patients with X4-tropic virus has been completed.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) [Phase 1]
A Phase 1 clinical trial update evaluating hydroxychloroquine for HIV-infected individuals with discordant CD4 responses on HAART; the curre…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects [Phase 1]
Phase 1 trial in healthy adults assessing safety, tolerability, and pharmacokinetics of repeat-dose injections of long-acting cabotegravir a…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana [Phase 4]
A Phase 4 clinical trial in Botswana comparing limited versus continuous isoniazid preventive therapy for tuberculosis prevention in HIV-inf…
-
CLINICAL_TRIALS other · 2014-02-05Clinical Trial Update: Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) [Phase 3]
Phase 3 clinical trial ANRS 147 OPTIPRIM evaluating optimization of treatment for primary HIV-1 infection has completed.
-
FDA approval · 2014-02-03FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved a generic lamivudine and zidovudine combination tablet under an original ANDA for Exelan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults [Phase 3]
Phase 3 trial comparing GSK1349572 (dolutegravir) to raltegravir in antiretroviral-experienced, integrase inhibitor-naive adults; completed …
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Naïve HIV POC Monotherapy Trial [Phase 2]
Phase 2 trial evaluating a treatment-naive HIV POC monotherapy sponsored by Ardea Biosciences has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects [Phase 1]
A Phase 1 study evaluated the effect of the anticonvulsant carbamazepine on the pharmacokinetics of the HIV integrase inhibitor dolutegravir…